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INTRODUCTION 
 
Stem cells are implicated in preserving tissue 
homeostasis throughout life, by replacing damaged or 
lost cells. That is why an appropriate balance between 
self-renewal and differentiation is crucial for stem cell 
function during both early development and adult life. 
Recent studies suggest that this balance is partly 
regulated by reactive oxygen species (ROS) [1]. Indeed, 
physiological levels of ROS can have positive effects on 
the regulation of stem cell fate. In particular, oxidative 
stress is known to play an important role in modulating 
different stem cells properties, such as self-renewal, 
proliferation, differentiation and senescence [2]. 
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ABSTRACT 
 
Mesenchymal stem cells have emerged as an important tool that can be used for tissue regeneration thanks to 
their easy preparation, differentiation potential and immunomodulatory activity. However, an extensive 
culture of stem cells in vitro prior to clinical use can lead to oxidative stress that can modulate different stem 
cells properties, such as self-renewal, proliferation, differentiation and senescence. The aim of this study was to 
investigate the aging process occurring during in vitro expansion of stem cells, obtained from amniotic fluids 
(AFSC) at similar gestational age.  
The analysis of 21 AFSC samples allowed to classify them in groups with different levels of stemness properties. 
In summary, the expression of pluripotency genes and the proliferation rate were inversely correlated with the 
content of reactive oxygen species (ROS), DNA damage signs and the onset premature aging markers, including 
accumulation of prelamin A, the lamin A immature form. Interestingly, a specific source of ROS, the NADPH 
oxidase isoform 4 (Nox4), can localize into PML nuclear bodies (PML-NB), where it associates to prelamin A. 
Besides, Nox4 post translational modification, involved in PML-NB localization, is linked to its degradation 
pathway, as it is also for prelamin A, thus possibly modulating the premature aging phenotype occurrence. 
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The excessive generation of endogenous ROS and the 
imbalance between ROS and antioxidant systems, but 
also the culture of stem cells with various extracellular 
sources of ROS can lead to oxidative stress. This is the 
case of MSCs, whose low number requires ex vivo 
expansion prior to clinical use. At present, most of the 
expansion procedures of MSCs are performed under 
atmospheric O2 concentration (20% O2), which is 
approximately 4–10 times higher than the concentration 
of O2 in their natural niches [3]. This higher O2 
concentration might cause environmental stress to the in 
vitro cultured MSCs, due to the increased ROS 
concentration. Recently, the review by Choi et al. [4] 
reported studies demonstrating that hypoxia has a 
greater ability to preserve the stemness of human 
Adipose SCs, (ASC) as indicated by the increased 
expression of stemness genes (e.g., NANOG, SOX-2, 
OCT4, and REX-1).  
 
In general, oxidative stress due to high ROS levels 
impairs stem cell homeostasis and can induce DNA 
damage, cell cycle arrest and eventually a senescence 
phenotype [5]. Indeed, long-term ASC expansion at low 
O2 (5%) revoked in part the replicative senescence-
associated alterations [6]. 
 
Senescence, defined as a series of cellular changes 
associated with aging, results from an impaired signal 
transduction program leading to irreversible arrest of 
cell growth and a distinct set of changes in the cellular 
phenotype [7, 8]. Cellular senescence can be induced 
prematurely by various agents and stimuli [9] and the 
free-radical theory of aging postulates that the 
production of intracellular ROS is the major 
determinant of lifespan [8].  
 
During physiological aging, minor forms of 
lipodystrophy are present and a slight prelamin A (PLA) 
accumulation is observed [10]. A-type lamins are 
nuclear proteins required for the structural and 
functional integrity of the nucleus. Lamin A is 
translated as a protein precursor that undergoes several 
maturation steps, including the addition of a C-terminal 
farnesyl residue, which is subsequently removed by 
proteolytic cleavage [11]. Defective physiological 
maturation of prelamin A is the main 
pathophysiological mechanism underlying several 
premature aging syndromes, including the Hutchinson-
Gilford progeria syndrome (HGPS) [12].  
 
It is becoming increasingly clearer that, next to its 
structural function and role in nuclear dynamics [13], 
the nuclear lamina also modulates intracellular redox 
homeostasis [14]. Various studies revealed not only that 
ROS levels are increased in laminopathy patient cells 
and during prelamin A accumulation, but also that this 
increase may be attributed to dysfunctional 
mitochondria [15-18]. Others studies observed that 
prelamin A accumulation in human MSCs gives rise to 
a premature aging phenotype that ultimately causes 
reduced functionality of these cells in vivo [19]. In fact, 
using a human in vitro model of LMNA-lipodystrophy, 
it has been shown that prelamin A accumulation causes 
defects in the differentiation of human MSCs to 
adipocytes [20]. Moreover, a number of studies 
indicates that the molecular mechanisms causing 
accelerated aging in progeric patients also occur in 
healthy cells of older population [21]. How fast and 
how healthy the aging occurs is also dependent on the 
individual specificity and its living habits. 
 
The aim of this study was to investigate the aging 
process occurring in human MSCs during in vitro 
expansion. This process is certainly influenced by the 
oxidative stress exposure implied in extensive culture, 
but could also be donor dependent. The sample 
variability can be due both to the age of the donor and 
also to the individual characteristics. In order to restrict 
the age factor, stem cells obtained from amniotic fluids 
(AFSC), that is from foeti of similar gestational age, 
have been compared. The stemness properties, such as 
self-renewal and proliferation rate, have been correlated 
to the onset of senescence and premature aging markers. 
Then we investigated the relationship between a ROS 
producing enzyme and prelamin A accumulation into 
the nuclear foci of AFSC samples during the aging 
process. All in all, the results of this study may also 
explain some of the cellular changes occurring during 
normal aging, focusing on the role of stem cells 
subpopulation. 
 
RESULTS 
 
Characterization of hAFSCs cultures obtained from 
amniotic fluids of physiological pregnancy 
 
21 amniotic fluids were collected at 16th-17th week of 
pregnancy from healthy donors: foeti did not carry 
genetic abnormalities, pregnancies showed only in one 
case preeclampsia complication, but the Apgar score of 
all the new-borns was 9/10 and no one child needed 
assistance in neonatology. Women (average age 36.4) 
led healthy habits of life, except one smoker mother. 
 
C-kit positive cells, selected from at least 1.5x106 cells, 
were 1-4 % of amniotic fluid cells. Analysis of 
cumulative population doubling (CPD) during passages 
(up to 7th passage) established three groups of samples 
with different proliferation rate. The faster showed a 
trendline slope around 0.99 ± 0.01 R2 and the slower 
was 0.96 ± 0.02 R2. A graph representative of three all 
the samples is shown in Figure 1A. Analysis of 
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Population Doubling Time (PDT) at passage 3, 
therefore excluding the last part of the sigmoidal curve, 
confirmed that AFSC samples were distributed in three 
groups for the growth rate, as shown by coloured circles 
in Fig. 1B. Slower group showed a PDT value that 
doubled the faster one. 
 
These data on AFSCs are consistent with the 
observation that different proliferative capability of 
MSCs cultures isolated from different donors exists [22, 
23]. The proliferation rate of AFSCs achieved its 
maximum level at passage 3 and, after passages 6-7, 
there was a decline in the efficiency of proliferation in 
all cell populations. Concurrently, also the analysis of 
flow cytometry was performed, to determine 
immunophenotype that still represents one of the major 
parameters for the characterization of MSCs cultures. 
As shown in Figure 1C, AFSCs from four 
representative samples were positive for mesenchymal 
markers, such as CD29, CD44, CD73, CD90, and 
CD105. Samples at early passages (not over the 4th 
passage) maintained a quite similar level of cell surface 
markers CD29, CD44, CD73 and CD105, although 
CD90 seemed to be the more variable.  
 
A potential marker of the senescent state of stem cells 
may be also a decreased expression of pluripotency 
transcription factors, such as Nanog, Sox2, SSEA4, and 
Oct4 [24]. Therefore, to confirm stem cell origin of 
AFSCs, we performed cytofluorimetric analysis of the 
main transcription factors from AF samples with slow 
(group I, n = 3), middle (group II, n=3) and high (group 
III, n = 3), proliferation (Fig. 1D). Sox2 and SSEA4 
were expressed at a quite similar level in all AFSC 
samples, while the expression of Oct4 and Nanog were 
much lower in slow samples (group I).  
 
 
Figure 1. hAFSCs derived from amniotic fluid of physiological pregnancy: comparison of the proliferation capability 
and stemness profile.  (A) The graph shows the cumulative population doubling (CPD) calculated up to the 7th passage in culture 
for all the samples. (B) Population doubling time (PDT) values of all the samples, evaluated at the third passage in culture. (C) 
Quantitative analysis by flow cytometry of four representative samples for the expression of the surface markers: CD44, CD73, CD29, 
CD105, CD90. (D) Graph showing the cytofluorimetric analysis of Nanog, Oct4, Sox2, SSEA4 expression among the three groups. ***P 
< 0.0001; **P < 0.01 =  significantly different from group I, ###P < 0.0001; ##P < 0.01 =  significantly different from group II. 
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Figure 2. Senescence-associated markers profile.  (A) Representative images of beta-galactosidase assay performed in group I 
(faster senescent cells) and group III (slower senescent cells) samples at passage 6 and 9, respectively. Senescent cells are blue 
stained. Scale bar=30 µm. (B) Western Blot analysis of total hAFSCs lysates revealed with anti-p16 antibody. Tubulin detection was 
performed as a loading control. The graph shows densitometric analysis of Western Blot experiment. Group I samples were set as 1. 
Data are representative of three independent experiments (***P < 0.0001; **P < 0.01). (C) Representative confocal images of group I, 
II and III samples double staining with DAPI (blue) and p53 (green), p21 (red), pH2A (red). Scale bar= 10 µM 
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Senescence-associated molecular changes in AFSCs 
cultures 
 
Several biomarkers have been used for quantitative 
assessment of cell senescence, including senescence-
associated 𝛽𝛽-galactosidase (SA-𝛽𝛽 gal) and the cyclin-
dependent kinase inhibitors, p16INK4A and p21WAF1, 
that are involved in the control of growth arrest by two 
major tumour suppressor pathways, p16INK4A/pRb 
and p53/p21WAF1 [25, 26]. As shown, during 
passaging of cell cultures derived from different AF 
donors, AFSCs cultures differently stop their growth in 
the course of cultivation. In fact, we observed that 
AFSCs senescence was accompanied by typical 
morphological changes and cells became enlarged and 
flattened, with enhanced SA-𝛽𝛽-gal activity (Figure 2A), 
while stem cell marker expression decreased, as 
reported for Oct4, as a representative marker, in 
Supplementary Figure S1. These senescence-associated 
changes occurred later in AFSCs samples that showed a 
relatively faster level of proliferation. Indeed, at early 
passages a slight more intense positivity for SA-𝛽𝛽-gal 
activity is more evident for group I than group III 
(Supplementary Figure S2), while the same amount 
(about 70%) of SA-𝛽𝛽-gal-positive cells was detected in 
groups I and III at p6 and p9 (denoted as late passage), 
respectively.  
 
To gain insight into the molecular characteristics of 
AFSCs senescence, we analysed protein level profiles 
of classical senescence-associated markers, p16INK4A 
(p16), p21WAF1 (p21), p53, and pH2A.X as DNA 
damage index, in all groups of cell cultures at late 
passage. As demonstrated by Western Blot analysis, 
AFSCs cultures of group I showed higher p16 
expression, as compared to group III (Figure 2B), so the 
level of p16 expression seemed to be inversely 
correlated with the proliferation capability. Moreover, 
we observed by confocal images more positivity for p21 
and p53 expression in faster senescent cells (group I) 
than in group III, both in samples at late passage and at 
early passage, as shown in Figure 2C and S2. The 
analysis of the expression of pH2A.X showed a higher 
number of positive cells in group I, suggesting a 
correlation with expression levels of p16, p53/p21. 
 
Difference in nuclear redox state of AFSC groups 
 
Since oxidative stress can cause DNA damage, we 
tested total reactive oxygen species (ROS) levels in 
cultures at early (p1) and late passages (p7). The graph 
of Figure 3A shows that samples of group I (faster 
senescent cells) have a content of ROS 10 times higher 
than group II, both at the first and at the seventh 
passage.  
 
Moreover, we have previously demonstrated that a ROS 
producing enzyme, the isoform 4 of NADPH oxidase 
(Nox4), localizes in a spot distribution into the nuclei of 
AFSC, depending on their cell cycle state [27]. Here we 
can confirm this observation, thanks to a larger cohort 
of samples better characterized for clinical aspects and 
stem cell features. Indeed, the higher Nox4 nuclear 
localization in group I is shown in confocal images of 
Fig. 3B. Interestingly, the nucleoplasmic Nox4 is, in 
some images, not only in a spot-like but also in a ring-
like distribution. Western blot analysis of total lysates 
(Fig.3C) indicates the increase, during passaging of 
group II AFSC, of a double band at 74-72 kDa. 
Moreover, the highest intensity of 72 kDa band is 
detectable in group I (faster senescent cells).  
 
Sirtuins are a class of NAD+-dependent protein 
deacylases with important implications in aging [28]. 
Humans have 7 sirtuins (SIRT1–7) with distinct 
subcellular localizations and functions. The regulatory 
role of Sirtuin 1 (SIRT1) is predominantly linked to p53 
activity. Interestingly, its activation in aged cells 
protects the cells from p53-dependent apoptosis or 
senescence [29]. It was found that oxidative stress 
regulates these sequences and promotes shuttling of 
SIRT1 [30, 31]. Here we found that samples of group I 
have an expression of SIRT1 much lower than group 
III, and the effect of culture passaging is a decrease of 
SIRT1 expression, as expected (Fig. 3C). 
 
Nox4 and prelamin A interaction in AFSC groups 
 
Preliminary mass spectrometry analysis of proteins co-
immunoprecipitating with Nox4 extracted from isolated 
nuclei hinted at the interaction of Nox4 with lamin A 
proteins (Supplementary Figure S3). However, since 
nuclear Nox4 staining does not overlap neither with 
nuclear envelop nor with nucleoli, we wondered if this 
interaction could involve an immature form of lamin A, 
such as prelamin A. Immunostaining of prelamin A and 
farnesylated prelamin A in AFSC revealed an extensive 
presence of punctate dots and fibrous aggregates at later 
passages in group II (Fig. 4A), but also at early passage 
in group I (faster senescent cells). Interestingly, some 
cells from group I samples showed a drop-like staining, 
likely localized into nucleoli.  
 
Double staining for prelamin A and pH2A.X revealed 
that the simultaneously labeling in the same cell 
scarcely occurs, as shown in Supplementary Figure S4. 
 
Conversely, double staining for Nox4/prelamin A and 
Nox4/farnesylated prelamin A showed a partial 
colocalizations of these two proteins in the nuclear spots 
(Fig. 4B).  
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Figure 3. ROS levels and ROS modulating proteins in AFSC groups.  (A) Representative graph showing fluorescence, obtained 
with ROS probe (DCFH-DA), normalized to MTT viability values of hAFSCs samples at 1st and 7th culture passage. ***P < 0.0001; **P < 
0.01 significantly different from group III. (B) Representative images showing DAPI (blue) and Nox4 (green) signals of the three 
different hAFSCs groups. Scale bar= 10 µm. (C) Representative images of Western blot analysis of AFSC samples, group I, II and III (Gr 
I-Gr III, faster to slower senescent cells) at passage 4, or group II at passage 1, 4 and 8 (P1-P8), revealed with anti-Sirt1 and anti-Nox4 
antibody. Tubulin detection was performed as a loading control. Data are representative of three independent experiments.  
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Figure 4. Nox4 interaction with prelamin in nuclei of AFSC.  (A) Representative images of AFSC group I, II and III (faster to 
slower senescent cells) showing green signals of Prelamin A (Prelam A), and, in doubled magnification image in white square of group 
II, farnesylated Prelamin A (farn Prel). Scale bar= 10 µm. (B) Representative images of AFSC group II labelled with DAPI (blue), Nox4 
(green) and Prelamin A (red) or farnesylated Prelamin A (red). Scale bar=10 µm. (C) Western Blot analysis revealed with anti-Prelamin 
A or the specific anti-Lamin A/C antibodies of total hAFSCs lysates of group II at passage 1, 4 and 8 and of group I, II and III at passage 
4. Tubulin detection was performed as a loading control. Mevinolin (Mev) treatment was performed to show a prelamin A positive 
control. Data are representative of three independent experiments. (D) Western blot analysis of total lysate (TL) and 
immunoprecipitation (IP) experiment of TL with Prelamin A or farnesylated Prelamin A antibody then revealed with anti-Nox4. 
Preclearing samples were also loaded, in order to exclude non-specific signals. Data are representative of three independent 
experiments. (E) Western blot analysis of nuclear lysate (NL) and immunoprecipitation experiment of Nuclear lysate (IP Nu) and 
Cytoplasmic lysate (IP Cy) with Nox4 antibody then revealed with anti-Prelamin A. Mevinolin (Mev) treatment was performed to 
show a prelamin A positive control. Data are representative of three independent experiments. 
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This prelamin A accumulation, during passaging, was 
confirmed also by Western blot analysis (Fig. 4C), 
suggesting a positive correlation between prelamin A 
expression and cell aging, parallel to Nox4 increase. 
Indeed, Western blot of Figure 4C probed with anti-
prelamin A demonstrates the presence of a higher band 
(74 kDa), that is more expressed in samples from group 
I (faster senescent cells), although at lower intensity as 
compared to the positive control (cells treated with 
mevinolin). Moreover, the band corresponding to 
mature lamin A decreased: this effect is consistent with 
an accumulation of its immature form, prelamin A. The 
accumulation of nuclear Nox4 and prelamin A can be 
reduced by the ROS decrease, by treating cell culture 
with natural antioxidants, as shown in Figure S5. These 
two phytochemicals, sulforaphane (SF) and 
epigallocatechin gallate (EGCG), were chosen since 
they possess different chemo-physical properties 
(EGCG is more hydrophilic than SF) and because they 
could modulate various cell pathways. 
 
Moreover, this increase is negatively correlated to the 
adipogenic differentiation capability of AFSC: Figure 
S6 shows that group II, that presents a medium 
stemness profile but accumulates prelamin A, after 
exposure to adipogenic medium for 3 weeks, expressed 
a significantly lower level of the adipogenic marker 
PPARγ, compared to group III. 
 
In Fig. 4D AFSC total cell extracts immunoprecipitated 
with an anti-prelamin A or farnesylated prelamin A 
antibody and then immunoblotted with anti-Nox4 are 
shown. We detected high molecular weight (74 kDa) 
band indicative of Nox4 interaction with both the 
immature forms of lamin A. 
 
This interaction was confirmed by immunoprecipitation 
of nuclear lysates with anti-Nox4 antibody, detected for 
anti-prelamin A, as shown in Figure 4E. 
 
Nox4-prelamin A interaction: what is the meaning? 
 
It has been reported that SIRT1 is recruited by 
promyelocytic leukemia (PML) protein to nuclear 
bodies (PML-NBs) and SIRT1 can rescue mouse 
embryonic fibroblasts from PML-induced premature 
senescence [32]. Given the involvement of PML-NBs in 
aging and in protein sequestration/degradation and the 
similarity between their structure and that of 
Nox4/prelamin A intranuclear aggregates, we 
hypothesized that these compartments might be 
involved in their nuclear accumulation. 
 
We first explored the localization of PML protein in the 
different AFSC groups. PML-NBs morphology and 
number were low in patients of group III (slower 
senescent cells), with PML-NBs appearing as classical 
punctate structures (Fig. 5A). In group I (faster 
senescent cells), the dimension of classical PML-NBs 
increased and the number of aberrant ring-like and 
thread-like PML-NBs appeared (Fig. 5A). 
 
We then checked whether prelamin A colocalized with 
these structures, and we could observe that this was the 
case (Fig. 5B). Double immunostaining with anti-PML 
and anti-prelamin A antibodies on AFSC group I using 
confocal microscopy showed that part of intranuclear 
farnesylated prelamin A content colocalized with the 
PML bodies, seeming to be sequestered inside them in 
some regions. A similar result was obtained for Nox4 
and PML double staining. 
 
PML protein is degraded through a SUMO-triggered 
RNF4/ubiquitin-mediated pathway, and most PML-
associated proteins undergo SUMO-conjugation [33]. 
To investigate post translational modification of nuclear 
Nox4, we carried out immunofluorescence experiments, 
using Nox4 and SUMO1 antibodies on AFSC from 
group I (faster senescent cells). As shown in Fig. 5C, 
Nox4 and SUMO1 staining colocalized into PML-like 
intranuclear foci. 
 
Western blot using SUMO1 antibody in Nox4 
immunoprecipitated nuclear or cytoplasm lysates 
revealed that nuclear Nox4 is directly linked to SUMO1 
or through another sumoylated protein with 74 kDa 
molecular weight, such as prelamin A (Fig. 5D), 
corroborating Nox4 localization within PML-NBs.  
 
To better determine the effect of Nox4 sumoylation, we 
treated AFSC of group II, since it shows intermediate 
features, with a membrane permeable sumoylation 
inhibitor (anacardic acid) [34]. Data shown in Figure 
6A, by Western blot and immunofluorescence analyses, 
highlighted that SUMO inhibition caused an increase of 
Nox4 presence, both nuclear and cytoplasmic, 
suggesting that the inhibition of general sumoylation 
causes a block in the degradation pathway of Nox4. 
 
To determine whether proteasome inhibitors may 
influence the levels of nuclear Nox4, we performed 
treatment with MG132, an inhibitor of the proteasome 
pathway, and investigated Nox4 expression by Western 
blot and localization by immunofluorescence. Figure 6B 
indicates that MG132 induced an increase in Nox4 
levels both in the cytoplasm but also into the PML 
nuclear foci. Since it has been demonstrated [35] that 
the effect of MG132 in Hutchinson-Gilford progeria 
syndrome (HGPS) fibroblasts unexpectedly resulted in a 
decrease of progerin staining intensity, instead of 
increasing progerin levels, we carried out 
immunofluorescence   experiments   for   farnesylated  
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Figure 5. Nox4 post-translational modification in nuclei of AFSC.  (A) Representative images showing DAPI (blue) and PML 
(red) of AFSC of group I and III. Tripled magnification image is present in white square of group I. (B) Representative images of AFSC 
group I (faster senescent cells) showing superimposing of DAPI (blue), farnesylated prelamin A (green) or Nox-4 (green) and PML 
(red). Tripled magnification image is present in white square of both. Scale bar= 10 µm. (C) Representative confocal image of AFSC 
group I samples labelled with Nox4 (green) and SUMO1 (red). Scale bar= 10 µM. (D) Western blot analysis of nuclear lysate (Nu), 
cytoplasmic lysate (Cy) and immunoprecipitation experiment of Nu and Cy with Nox4 antibody then revealed with anti-SUMO1. Data 
are representative of three independent experiments. 
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prelamin A. As shown in Fig. 6B, 8-h treatment with 
MG132 induced the formation of large farnesylated 
prelamin A and PML intranuclear foci, not a decrease.  
 
DISCUSSION 
 
ROS have a role in DNA damage accumulation in 
human stem cells and have a major impact on stem cell 
aging. Indeed, our results show that there are 
differences in the stemness profile of AFSCs during in 
vitro expansion, due to donor variability. One third of 
AFSC samples showed a low proliferation rate, linked 
to poor expression level of pluripotency markers and 
faster senescence occurrence, as well as higher total 
ROS production. Interestingly, these phenomena were 
accompanied to the accumulation in the nucleoplasm of 
lamin A precursors, unexpected effect since these are 
stem cells of foetal age. At the same time, the presence 
of Nox4, a ROS enzymatic source, increased in the 
sumoylated form into the nuclei localizing in PML 
 
 
Figure 6. Effect of Anacardic Acid and MG132 treatment on Nox4 expression.  (A) Representative image of Western blot 
analysis of AFSCs group II samples (intermediate senescent cells) used as control (0) or treated with anacardic acid for 24 h and then 
revealed with anti-Nox4. Tubulin detection was performed as a loading control. Data are representative of three independent 
experiments. On the right, representative images showing superimposing between DAPI (blue) and Nox-4 (green) of control or 
anacardic acid treated samples. Scale bar= 10 µm. (B) Representative image of Western blot analysis of AFSCs group II samples used 
as control (0) or treated with MG132 for 8 h and then revealed with anti-Nox4. Tubulin detection was performed as a loading control. 
Data are representative of three independent experiments. On the right, representative images showing superimposing among DAPI 
(blue), Nox-4 (green) or farnesylated Prelamin (green) and PML (red) of control or MG132 treated samples. Scale bar= 20 µm. 
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bodies and interacting with immature lamin A. This 
localization is a way to sequester and favour proteasome 
degradation, with the possible protecting meaning to 
modulate ROS content, limit DNA damage and induce 
senescence.  
 
Our study was based on the statement that in vivo stem 
cells reside within a hypoxic niche that preserves MSC 
progenitor properties [36], while in vitro culture of stem 
cells is routinely performed at atmospheric oxygen 
tension that leads to abnormal production of ROS. The 
excess of intracellular ROS deeply impacts on stem cell 
functionality, particularly proliferation and 
differentiation [37], thus mimicking and shortening the 
aging process. We hypothesized, however, that an 
intrinsic ROS susceptibility, depending on individual 
variability, is an important modulator in stem cell 
power, both in vitro and in vivo. Indeed, here we 
confirmed that stem cells of the same foetal age, taken 
from healthy pregnancies, show marked differences in 
the proliferation rate and in the timing of senescence 
occurrence since the first passage in culture. In fact, 
slower samples express low levels of stemness markers, 
since the earliest passages in culture. However, we did 
not observe significant differences in mesenchymal 
marker expression, and this may be due to our analyses, 
that were all conducted at the same early passage. Our 
findings are consistent with the study of Bertolo et al. 
[38] where adult MSC isolated from donors of the same 
age showed distinctive behaviour in culture, 
demonstrating the importance of mitochondrial function 
in MSC in vitro, and that cells with low oxidative status 
levels are better candidates for cell-based therapies. 
Collectively, our data suggest a picture of donor-
dependent heterogeneity in stem cells efficacy, that not 
only points the attention to the need to attentively 
screen stem cells samples prior to undertake 
regenerative therapy approaches, but it could also be a 
mirror of an intrinsic and individual inclination to a 
premature aging progression. 
 
The response of stem cells to oxidative stress is not well 
understood, but it has been related to increased double-
stranded DNA breaks, faster telomere shortening for 
MSCs cultured in ambient condition [39] and prelamin 
A accumulation, which may be due to mitochondria 
derived-ROS that give rise to a premature aging 
phenotype [40]. Here we showed that low oxidative 
status levels, obtained with antioxidant treatment, 
prevented nuclear prelamin A accumulation. Indeed, 
alteration in the nuclear profile and in chromatin 
organization, which are particularly impressive in 
systemic laminopathies, whose cells undergo premature 
senescence, are mainly due to accumulation of 
unprocessed prelamin A [17]. In fact, depletion of 
ZMPSTE24, the farnesylating enzyme of prelamin A, 
can trigger a senescence pathway associated with 
moderately increased ROS levels and transient Δψm 
depolarization [41]. These considerations are consistent 
with our data in the AFSC samples with a poor growth 
and stemness profile (group I), showing prelamin 
A/farnesylated prelamin A accumulation and a higher 
intracellular ROS content. The expression of prelamin 
A in cells of so young origin is still surprising but our 
data, comparing adipogenic differentiation capability of 
AFSC of different groups, are consistent with another 
paper reporting that, in an in vitro model of LMNA-
lipodystrophy, prelamin A accumulation causes defects 
in the differentiation of human MSCs to adipocytes 
[21]. We also noticed by immunofluorescence analysis 
that the cells positive for prelamin A rarely presented 
DNA damage markers, data that could suggest a 
protective role for prelamin A accumulation.  
 
Moreover, it has been reported that the nuclear lamina 
itself can also modulate intracellular redox homeostasis 
[14]. We previously reported that the nuclear 
localization of a ROS source, Nox4, is peculiar of some 
AFSC samples, with a correlation with the cell cycle 
state [27], but here we observed that Nox4 expression, 
during passaging or comparing cells of group III, II and 
I (slower to faster senescent cells), moves from the 
cytoplasm to a nuclear spot like distribution, and that 
this phenomenon occurs in AFSC already expressing 
farnesylated prelamin A, driving to a senescent 
scenario. Interestingly, we noticed that some AFSC 
samples of group III (slower senescent cells) express 
farnesylated prelamin A, but do not show nuclear Nox4 
distribution, suggesting that the modification in lamin A 
processing is an upstream event, as compared to Nox4 
accumulation into the nuclei. Taking into account this 
consideration, we can look at the interaction with Nox4 
inside the nucleoplasm as a response to the general 
redox imbalance occurring in these cells. In fact, a ROS 
decrease, due to antioxidant treatment, caused a 
decrease on prelamin and Nox4 nuclear signals, hinting 
at a role for high ROS as essential drivers of cellular 
aging. Moreover, the colocalization between these 
proteins is particularly evident into PML nuclear bodies. 
Indeed, promyelocytic leukemia nuclear bodies (PML-
NBs), discrete nuclear speckles tightly associated with 
the nuclear matrix and implicated in cellular senescence 
[42], have a nuclear arrangement that is influenced by 
A-type lamin deficiency [43]. Also, our data show an 
increase in PML-NBs dimensions and abnormal 
features in AFSC of group I (faster senescent cells), that 
contain high prelamin A levels and low SIRT1 
expression, compared to group III. Interestingly, SIRT1 
has been reported to be recruited by PML to PML-NBs, 
where it co-localises with p53, through inhibition of 
proapoptotic activity of p53 [32]. In this way, the 
regulation of SIRT1-p53 axis can modulate stem cell 
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fate. Indeed, p53 can also regulate miR-145 expression 
that is negatively associated with many genes involved 
in cell metabolism [44]. 
 
PML-NBs regulate posttranslational modifications of 
partner proteins like sumoylation, ubiquitination, but 
also phosphorylation or acetylation. These 
modifications involve a wide variety of partners, 
leading to modulation of biological processes like 
transcription, apoptosis/senescence, DNA repair, and 
stem cell self-renewal.  
 
SUMO is conjugated to target proteins on the side chain 
of lysine residues, creating a branched peptide and 
significantly changing the binding properties of the 
protein. SUMO has been implicated in multiple 
pathways, mostly as a regulator of protein interactions 
[45]. Interestingly, some reports have demonstrated 
sumoylation of lamin A at lysine 201 [46]. This 
sumoylation site is also present in prelamin A and could 
be involved in its translocation to PML-NBs, therefore 
we focused our attention only on the possible 
sumoylation of Nox4. It has been reported that, upon 
heat shock, SUMO1 is attached to another isoform of 
NADPH oxidase (Nox2), thus blocking its activity and 
consequently controlling redox status and protecting the 
cell from oxidative stress-induced death [47]. However, 
the analysis of Nox4 sequence highlighted the presence 
not only of sumoylation sites but also the presence of 
SUMO interaction motifs (SIM) close to them, that 
were very numerous. 
 
Since conjugated SUMO may interact with the short 
motif SIM and most partner proteins associated with 
classical PML-NBs are sumoylated and many contain a 
SIM motif, SIM/SUMO interactions may also account 
for partner recruitment as well as sequestration [48]. In 
this context, here we demonstrated the presence co-
immunoprecipitation of SUMO1 with nuclear Nox4, 
suggesting that SUMO modifications participate in 
Nox4 and prelamin interactions and cellular senescence, 
through modulation of oxidative stress responses.  
 
PML-NBs have been proposed to function also as 
sequestration sites of misfolded proteins targeted for 
proteasomal degradation [42]. However, the effect on 
progerin protein and treatment with proteasome 
inhibitor was not obvious, as Harhouri et al. observed 
progerin decrease upon proteasome inhibition that 
suggested that progerin could be a substrate for 
autophagic degradation as a compensatory response 
[35]. That is why we tested the effect of the proteasome 
inhibitor MG132, on farnesylated prelamin A and 
Nox4. Our data, also the one with the sumoylation 
inhibitor, confirmed that PML-NB sequestration via 
sumoylation modification may have a role in the 
proteasome degradation of these interacting proteins, 
events that could create an elimination flow of the ROS 
source Nox4, concentrating this protein in nuclear 
domains where a response to redox stress could be 
triggered and avoiding DNA damage maintaining the 
cells in a senescence state.  
 
In conclusion, these data demonstrate that, also in the 
younger and more plastic cells of our body, like AFSCs, 
differences in the capability to counteract oxidative 
stress exist among the individuals. Also, in the more 
sensitive cells protective mechanisms are activated, but 
these are signs of poor self-renewal properties for stem 
cells that are not efficient for therapeutic purpose.  
 
MATERIALS AND METHODS 
 
Amniotic fluid collection 
 
The hAFSCs were obtained from 21 amniotic fluids 
collected from women (average age 36.4 ± SD 3.2) 
between the 16th and 17th week of gestation who 
underwent amniocentesis at Arcispedale S. Maria 
Nuova Hospital in Reggio Emilia. During the pre-
amniocentesis interview, pregnant women were 
informed of the purpose of the study and of any risk 
related to. The informed consent was obtained, in 
accordance with the Italian law and the guidelines of the 
ethics committee (protocol 2015/0004362 dated 
02.24.2015). Informed consent, as well as all 
documentation relating to the invasive procedure, were 
signed by the pregnant women and by an ob-gyn 
specialist before continuing the exam.  
 
Supernumerary (unused) flask of AF cells cultured in 
the Laboratory of Genetics Arcispedale S. Maria Nuova 
for 2 weeks were trypsinized and treated to be freezed.  
 
Adult human tissue isolation and cell culture  
 
Human amniotic fluid stem cells (hAFSCs) were 
isolated as previously described by De Coppi et al. 2007 
[49]. Human amniocentesis cultures were harvested by 
trypsinization, and subjected to c-Kit immunoselection 
by MACS technology (Miltenyi Biotec, Germany). 
AFSC were subcultured routinely at 1:3 dilution and not 
allowed to expand beyond the 70% of confluence. 
AFSC were grown in culture medium (αMEM 
supplemented with 20% fetal bovine serum (FBS), 2 
mM L-glutamine, 100 U/ml penicillin and 100 μg/ml 
streptomycin (all from EuroClone Spa, Italy) at 37°C 
5% CO2. 
 
Adipogenic differentiation 
 
Cells were incubated for 3 weeks in adipogenic 
induction medium (culture medium supplemented with 
0.5 mM isobutylmethylxanthine, 1 mM dexamethasone, 
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10 mM insulin, 200 mM indomethacin, and 10% FBS). 
Medium was changed twice a week. Lipid-rich vacuoles 
within the cells were evaluated by Oil red O staining 
and AdipoRed assay (LONZA, Basel Switzerland), 
following the manufacturer’s instructions. 
 
ROS detection 
 
To evaluate intracellular ROS levels, dichlorodihydro-
fluorescein diacetate (DCFH-DA) assay was performed 
as previously described [50]. Cells were seeded in 96 
well plate at density of 3000 cells/well, 6 replicates. 
Cell culture medium was removed and the 5 μM DCFH-
DA was incubated in PBS glucose 5 mM for 30 min, 
37°C and 5% CO2. The cell culture plate was read at 
485 nm (excitation) and 535 nm (emission) using the 
Appliskan instrument (Thermo Fisher Scientific, 
Vantaa, Finland). 
 
Cell viability assay 
 
Viable cells were evaluated by the MTT assay. Cells 
were incubated with 0.5 mg/mL MTT for 4 h at 37 °C, 
as previously reported [50]. At the end of the 
incubation, purple formazan salt crystals were dissolved 
by adding the solubilization solution (isopropanol, 0.1 
M HCl). The absorption at 570 nm was measured on a 
multiwell plate reader (Appliskan, Thermo Fisher 
Scientific, Vantaa, Finland). 
 
Cell proliferation assays 
 
The proliferation rates of hAFSCs were analysed as 
previously reported [51]. After reaching confluence, 
adherent cells, isolated as described above, were 
trypsinized and seeded in T25 cm2 flask at a density of 
2x103 cells/cm2, cultured for 3.5 days then detached, 
counted and seeded again at 2x103 cells/cm2. Cell 
density was expressed as the mean of cells/cm2 ± SD. 
Cultures were performed until passage 8. The following 
formula was applied to all samples: 
 
PD = [log10NH – log10NS]/ ÷ log102 
 
where PD is the population doubling, NS is the cell 
number at seeding (2 × 103 cells/cm2) and NH is the cell 
number at harvest. To calculate the cumulative number 
of population doublings (CPD), the PD determined for 
each passage was then added to the CPD of the previous 
passage. 
 
The population doubling time (PDT) was calculated in 
the phase of exponential growth by the following 
formula:  
 
PDT log10(2)x∆T/log10(NH)-log10(N1d) 
where ∆T represents the time between the cell 
harvesting and seeding, NH represents the harvested 
cell number and N1d represents the cell number at day 
1. 
 
Senescence assay 
 
In order to evaluate the presence of senescent cells in 
AFSCs of samples, cells at passage 7-9 were seeded in 
12-well plates and processed using a senescence β-
Galactosidase staining kit (Cell Signaling, MA, USA), 
according to the manufacturer’s instructions.  
 
Flow cytometer immune-assay 
 
AFSCs at first passage were sub-cultured until reaching 
80% confluence. As previously reported [51], following 
trypsin dissociation, cells were stained with the 
following antibodies (mAbs): Rabbit-Thy-1 (CD90) and 
Rabbit-Endoglin (CD105) (Millipore, CA, USA), 
Mouse-SSEA4 (Cell Signaling Technology, MA, USA), 
Goat-Integrin β1 (CD29), Rabbit-HCAM (CD44) (Santa 
Cruz Biotechnology, CA, USA), Mouse-5’-
Nucleotidase (CD73) (Gene Tex, CA, USA). 
 
The expression of surface markers was analysed by 
indirect staining using secondary fluorochrome Alexa 
488-conjugated antibodies (Abcam, Cambridge, UK). 
Non-specific fluorescence was assessed by using the 
secondary antibody alone. A minimum of 5,000 cells 
per sample was acquired and analysed using FACScan 
flow cytometer and Lysis II software (both from Becton 
Dickinson, San Jose, CA, USA).  
 
The same cell samples were analyzed for nuclear stem 
cell markers, such as Goat- Sox2 (Santa Cruz 
Biotechnology, CA, USA) and Rabbit-Nanog and 
Rabbiti-Oct4, (Cell Signaling, MA, USA), after 
Fixation/Permeabilization process performed with the 
Staining Buffer Set (Miltenyi Biotec Inc, Auburn, CA, 
USA) optimized for nuclear staining. 
 
After exposure to adipogenic differentiation medium, 
nuclear differentiation marker rabbit anti-PPAR (Santa 
Cruz, CA, USA) was analysed by using the Staining 
Buffer Set (Miltenyi Biotec Inc, Auburn, CA, USA). 
 
Cell treatment and preparation of cell extracts 
 
Cells were treated with 10 µM Mevinolin (2-Methyl-
1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-
4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 
ester butanoic acid)  for 16 hours (Sigma-Aldrich, St 
Louis, MO, USA), or with 50 µM Anacardic Acid (2-
Hydroxy-6-pentadecylbenzoic acid) for 24 hours 
(Sigma-Aldrich, St Louis, MO, USA), or with 10 µM 
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MG-132 (benzyloxycarbonyl-Leu-Leu-Leu-aldehyde) 
for 8 hours (Selleckchem, Houston, TX, USA). 
 
Cell extracts were obtained as described by Maraldi et 
al. [27]. Briefly, subconfluent cells were extracted by 
addition of AT lysis buffer (20 mM Tris-Cl, pH 7.0; 1% 
Nonidet P-40; 150 mM NaCl; 10% glycerol; 10 mM 
EDTA; 20 mM NaF; 5 mM sodium pyrophosphate; and 
1 mM Na3VO4) and freshly added Sigma Aldrich 
Protease Inhibitor Cocktail at 4°C for 30 min. Lysates 
were sonicated, cleared by centrifugation and 
immediately boiled in SDS sample buffer or used for 
immunoprecipitation experiments, as described below. 
 
Nuclei purification  
 
Human AFSC nuclei were purified as reported by Guida 
et al. [52]. Briefly, 400 μl of nuclear isolation buffer (10 
mM Tris-HCl, pH 7.8, 1% Nonidet P-40, 10 mM β-
mercaptoethanol, 0.5 mM phenylmethylsulfonyl 
fluoride, 1 μg/ml aprotinin and leupeptin, and 5 mM 
NaF) were added to 5x106 cells for 8 min on ice. MilliQ 
water (400 μl) was then added to swell cells for 3 min. 
Cells were sheared by passages through a 22-gauge 
needle. Nuclei were recovered by centrifugation at 400 
× g at 4°C for 6 min and washed once in 400 μl of 
washing buffer (10 mM Tris-HCl, pH 7.4, and 2 mM 
MgCl2, plus inhibitors, as described earlier in the text). 
Supernatants (containing the cytosolic fractions) were 
further centrifuged for 30 min at 4000 × g. Isolated 
nuclear and cytoplasmic extracts were finally lysed in 
AT lysis buffer, sonicated, and cleared by 
centrifugation. 
 
Immunoprecipitation and Western blotting 
 
Immunoprecipitation was performed as reported by 
Guida et al. [52]. Equal amounts of precleared lysates, 
whose protein concentration was determined by the 
Bradford method, were incubated overnight with 
Rabbit-Nox4 (Santa Cruz Biotechnology, CA, USA), 
Rabbit-Prelamin A (Diatheva, Fano, PU, Italy), Rabbit- 
Farnesylated Prelamin A (Diatheva, Fano, PU, Italy) (3 
μg all). Then the two samples were treated with 30 μL 
of 50% (v/v) of protein A/G agarose slurry (GE 
Healthcare Bio-sciences, Uppsala, Sweden) at 4 °C with 
gentle rocking for 1 h. Pellets were washed twice with 
20 mM Tris-Cl, pH 7.0; 1% Nonidet P-40; 150 mM 
NaCl; 10% glycerol; 10 mM EDTA; 20 mM NaF; 5 
mM sodium pyrophosphate, once with 10 mM Tris-Cl, 
pH 7.4, boiled in SDS sample buffer, and centrifuged. 
Supernatants were loaded onto SDS-polyacrylamide 
gel, blotted on Immobilon-P membranes (Millipore, 
Waltham, MA, USA), and processed by Western blot 
with the indicated antibodies, detected by Supersignal 
substrate chemiluminescence detection kit (Pierce, 
Rockford, IL, USA). Quantitation of the signal was 
obtained by chemiluminescence detection on a Kodak 
Image Station 440CF and analysis with the Kodak 1D 
Image software. Primary antibodies were raised against 
the following molecules: Rabbit-p16 (Abcam, 
Cambridge, UK), Mouse-Tubulin (Sigma-Aldrich, St 
Louis, MO, USA), Mouse-SIRT1 (Cell Signaling 
Technology, MA, USA), Rabbit-Nox4 (Santa Cruz 
Biotechnology, CA, USA), Rabbit-Prelamin A 
(Diatheva, Fano, PU, Italy), Mouse-Lamin A/C (Santa 
Cruz Biotechnology, CA, USA), Rabbit-SUMO1 (Cell 
Signaling Technology, MA, USA). 
 
SDS-PAGE and Coomassie brilliant blue staining  
 
Nox4- immunoprecipitated samples were separated by 
10% SDS-PAGE and gels were then stained in the 
Coomassie brilliant blue solution (0.1% Coomassie blue 
in 10% acetic acid, 45% methanol) and shaken at room 
temperature for 1 h. The gels were destained by soaking 
for 2 h in destaining solution (10% acetic acid, 30% 
methanol).  
 
Mass spectrometry 
 
In-gel trypsin digestion and mass spectrometry analyses 
were performed as discussed in Shevchenko et al. [53]. 
Briefly, the stained bands were reduced in gel pieces 
that were treated with solution A (1:1 mixture of 
acetonitrile: 100 mM ammonium bicarbonate) for 30 
min. The gel slices were subjected to reduction of 
disulfide bonds by 10 mM DTT at 56°C for 30 min. 
Alkylation step was then performed with 55 mM 
iodoacetamide for 20 min at room temperature in dark. 
Before trypsin digestion, the rehydration and 
dehydration steps were again performed with 
ammonium bicarbonate and solution A. Then samples 
were incubated at RT with acetonitrile until gel pieces 
become white. Trypsin digestion was performed by 
incubating the dry gel slices overnight in 1 µg of trypsin 
in ammonium bicarbonate (Trypsin Sigma) at 37°C. 
Following digestion, the tryptic digested fragments 
present in the supernatant were collected and 
lyophilized. Before mass spectrometry analysis, the 
lyophilized powder was dissolved in 0.1% TFA in 50% 
acetonitrile. The expressed proteins were identified 
using LC/MS/MS 6410B mass spectrometer. Protein 
identification against the peak list was performed in 
MASCOT version 2.1 with Swiss-Prot and cRAP 
database as the search engine. The search parameters for 
database search using Mascot were given as, taxonomy: 
human; enzyme used for digestion: trypsin with one 
missed cleavage allowed; fixed modification specified 
as carbamidomethylation (C), and oxidation (M) and 
deamidated (NQ) as variable modifications. The peptide 
mass tolerance was set as 40 ppm and 0.08 Da for 
MS/MS tolerance. 
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Immunofluorescence and confocal microscopy  
 
For immunofluorescence analysis, samples were 
processed as previously described [52]. Confocal 
imaging was performed by a Nikon A1 confocal laser 
scanning microscope, as previously described [54]. 
Primary antibodies were raised against the following 
molecules: Rabbit-p53 (Flarebio, MD, USA), Mouse-
p21 (Novus Biologicals, CO, USA), Mouse-pH2A 
(Millipore, CA, USA), Rabbit-Nox4 (Santa Cruz 
Biotechnology, CA, USA), Mouse-Nox4 (Novus 
Biologicals, CO, USA), Rabbit-Prelamin A (Diatheva, 
Fano, PU, Italy), Rabbit-Farnesylated Prelamin A 
(Diatheva, Fano, PU, Italy), Mouse-PML (Santa Cruz 
Biotechnology, CA, USA), Mouse-SUMO1 (Novus 
Biologicals, CO, USA). 
 
The confocal serial sections were processed with 
ImageJ software to obtain three-dimensional 
projections. The image rendering was performed by 
Adobe Photoshop software.  
 
Statistical analysis 
 
In vitro experiments were performed in triplicate. For 
quantitative comparisons, values were reported as mean 
± SD based on triplicate analysis for each sample. To 
test the significance of observed differences among the 
study groups Student’s t-test or One-way Anova with 
Bonferroni post hoc test were applied. A P value <0.05 
was considered to be statistically significant. Statistical 
analysis and plot layout were obtained by using 
GraphPad Prism® release 5.0 software. 
 
Ethics approval and consent to participate 
 
An informed consent allowing the use of clinical data 
and biological samples for the specified research 
purpose (protocol 2015/0004362 of 02.24.2015) was 
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SUPPLEMENTARY MATERIAL 
  
 
 
Supplementary Figure S1. Oct4 decrease during culture passages.  Representative images of AFSC group I and III, at passage 
2 and 7, labeled with DAPI (blue), Oct4 (green). Scale bar=10 µm. 
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Supplementary Figure S2. Senescence marker at early passages for AFSC groups.  (A) Representative images of beta-
galactosidase assay performed in group I and III  samples at passage 2. Senescent cells are blue stained. Scale bar=30 µm. (B) 
Representative images of AFSC group II labeled with DAPI (blue), and p21(red) or p53 (green). Scale bar=10 µm. 
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Supplementary Figure S3. Mass spectrometry experiment.  Nuclear lysate of AFSC of group II was subjected to 
immunoprecipitation with Nox4 antibody. Image of Coomassie staining of proteins in IPnucNox4 separated by SDS-PAGE is shown. 
The mass spectrometry revealed that prelamin A/C protein was present, beside others, in the band highlighted in black. 
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Supplementary Figure S4. Prelamin A accumulation and DNA damage marker.  Representative images of AFSC group II 
labelled with DAPI (blue), Prelamin A (green) and pH2A (red). Scale bar=10 µm. 
 
www.aging-us.com 2933 AGING 
  
 
 
Supplementary Figure S5. Effect of ROS decrease on Nox4 and prelamin A accumulation.  Representative images of AFSC 
group I and III, treated or not with 1 µM sulforaphane (SF) and 10 µM epigallocathechin gallate (EGCG) for 11 days, labelled with DAPI 
(blue), Nox4 (green) and Prelamin A (red). Scale bar=10 µm. 
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Supplementary Figure S6. Adipogenic differentiation capability.  Graph showing the cytofluorimetric analysis of PPARγ 
expression among the groups II and III, after exposure to adipogenic differentiation. Four samples were analysed for each group. *P < 
0.05 =  significantly different from group II. 
 
